Stock Information
Grail Inc (GRAL)
Ticker Symbol: GRAL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,447.92 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -9.75
Revenue (TTM): $3.83 M
Dividend Yield: N/A
ROE: -15.88%
Latest News
-
Dow Jones Futures Fall As Treasury Yields, Oil Prices Keep Rising. Meta, Everpure, Grail Are Early Movers.
Thu, Sep 24, 2026 12:04 PM
-
The Holy Grail In Cancer? FDA Panel Backs Blood Tests
Wed, Sep 23, 2026 10:44 PM
-
FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test
Wed, Sep 23, 2026 10:17 PM
-
U.S. FDA Advisers Back Safety Of GRAIL's Galleri Multi-Cancer Screening Test; FDA Advisers Vote 6-4 That GRAIL's Galleri Is Effective For Proposed Use In Multi-Cancer Screening Test; Advisers Vote 7-2, With One Abstention, That Benefits Of GRAIL's Galleri Test Outweigh Risks For Proposed Use
Wed, Sep 23, 2026 6:07 PM
-
Meta's Muse Sends the Nasdaq to a Record and Rekindles the AI Trade
Tue, Sep 22, 2026 9:29 AM
-
Baird Maintains Outperform on GRAIL, Raises Price Target to $118
Tue, Sep 22, 2026 8:09 AM
-
GRAIL Stock Jumped 34% Yesterday. The FDA Just Told Its Investors Why.
Tue, Sep 22, 2026 6:07 AM
-
GRAL Stock Clocks Best Day In Over 1.5 Years — FDA Papers Lift Galleri Approval Hopes
Mon, Sep 21, 2026 8:50 PM
-
Grail Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test
Mon, Sep 21, 2026 8:14 PM
-
Let's take a look at the stocks that are in motion in today's session.
Mon, Sep 21, 2026 7:00 PM
Key Financials
Financial data not available